A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
Clinical trial NCT00728949 · COMPLETED
Trial details
- NCT number
- NCT00728949
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2012-03-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.